Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/2/2025

Management of Irritability in Children

Introduction to Irritability Management

  • The American Academy of Child and Adolescent Psychiatry recommends pharmacotherapy for children with irritability when there is a specific target symptom or comorbid condition, with risperidone being the most evidence-supported medication for severe irritability associated with aggression and tantrums 1
  • Drug withdrawal, in cases of prior in utero exposure, should be considered as an underlying cause of irritability in children beyond infancy 2

Assessment of Irritability

  • Clinicians should assess the severity and frequency of irritable episodes, associated symptoms, functional impairment, and temporal relationship to medication changes or stressors when evaluating irritability in children, as recommended by the American Academy of Child and Adolescent Psychiatry 3
  • Common causes like food allergies should be ruled out before considering psychiatric interventions for irritability in young children, according to the Mayo Clinic 4

Treatment of Irritability

  • For irritability with aggression in autism spectrum disorder, the American Academy of Child and Adolescent Psychiatry recommends risperidone (0.5-1 mg/kg/day) as the most evidence-supported option, with aripiprazole as an alternative 1
  • When addressing irritability associated with ADHD, the primary ADHD symptoms should be addressed with appropriate medication first, and then consider whether irritability is a side effect of stimulants or a core symptom, as suggested by the American Academy of Child and Adolescent Psychiatry 3

Medication Management

  • The American Academy of Child and Adolescent Psychiatry suggests starting with clear treatment targets, defining specific behaviors or symptoms to monitor, and using adequate medication trials to ensure appropriate dose and duration before determining efficacy 3
  • Regular assessment of target symptoms using standardized measures, monitoring for side effects, and reassessment if the child does not respond as expected are crucial in managing irritability, as recommended by the American Academy of Child and Adolescent Psychiatry 3
  • Clinicians should avoid mistaking reactions to psychosocial stressors as symptoms requiring medication and be cautious about using medications to address "all" of a patient's symptoms, according to the American Academy of Child and Adolescent Psychiatry 3
  • Certain medications, including SSRIs (e.g., sertraline) and aripiprazole, can contribute to irritability, with symptoms such as crying, irritability, tremors, poor suck, feeding difficulty, hypertonia, tachypnea, and sleep disturbance, as listed by the American Academy of Sleep Medicine and pediatric guidelines 5, 2
  • If a medication is determined to be the cause of irritability, consider dose reduction, switching to a different medication, or adjunctive therapy to manage irritability, and closely monitor patients for worsening irritability and other neuropsychiatric symptoms 2

REFERENCES

3

practice parameter on the use of psychotropic medication in children and adolescents. [LINK]

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

5

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008